Anna Żółkiewska

2.6k total citations
51 papers, 2.2k citations indexed

About

Anna Żółkiewska is a scholar working on Molecular Biology, Oncology and Immunology and Allergy. According to data from OpenAlex, Anna Żółkiewska has authored 51 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Oncology and 19 papers in Immunology and Allergy. Recurrent topics in Anna Żółkiewska's work include Cell Adhesion Molecules Research (19 papers), HER2/EGFR in Cancer Research (16 papers) and PARP inhibition in cancer therapy (10 papers). Anna Żółkiewska is often cited by papers focused on Cell Adhesion Molecules Research (19 papers), HER2/EGFR in Cancer Research (16 papers) and PARP inhibition in cancer therapy (10 papers). Anna Żółkiewska collaborates with scholars based in United States, Poland and Japan. Anna Żółkiewska's co-authors include Joel Moss, Yi Cao, Qing Kang, Michal Žółkiewski, Maria S. Nightingale, Hui Li, Danqiong Sun, Sara Duhachek-Muggy, Zhefeng Zhao and Ian J. Okazaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Anna Żółkiewska

50 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Żółkiewska United States 29 1.2k 934 440 393 359 51 2.2k
Ari Hashimoto Japan 25 1.4k 1.1× 588 0.6× 591 1.3× 269 0.7× 121 0.3× 47 2.3k
Susana Minguet Germany 25 900 0.7× 794 0.9× 1.1k 2.5× 159 0.4× 86 0.2× 63 2.5k
Lucia De Monte Italy 22 632 0.5× 823 0.9× 998 2.3× 145 0.4× 318 0.9× 50 2.1k
Scott R. Frank United States 17 2.5k 2.0× 622 0.7× 244 0.6× 113 0.3× 89 0.2× 20 3.0k
Heidi C. E. Welch United Kingdom 27 1.6k 1.4× 339 0.4× 652 1.5× 412 1.0× 55 0.2× 51 2.4k
Annalisa Frattini Italy 26 2.0k 1.7× 1.0k 1.1× 1.0k 2.3× 94 0.2× 56 0.2× 77 3.4k
Craig Mickanin United States 17 2.5k 2.1× 716 0.8× 317 0.7× 132 0.3× 50 0.1× 21 3.1k
Elisabetta Bianchi France 24 857 0.7× 408 0.4× 698 1.6× 255 0.6× 38 0.1× 51 1.9k
Peter Ping Lin United States 32 802 0.7× 950 1.0× 608 1.4× 130 0.3× 48 0.1× 69 2.5k
Benjamin P. Bohl United States 11 1.4k 1.2× 388 0.4× 618 1.4× 379 1.0× 38 0.1× 13 2.3k

Countries citing papers authored by Anna Żółkiewska

Since Specialization
Citations

This map shows the geographic impact of Anna Żółkiewska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Żółkiewska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Żółkiewska more than expected).

Fields of papers citing papers by Anna Żółkiewska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Żółkiewska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Żółkiewska. The network helps show where Anna Żółkiewska may publish in the future.

Co-authorship network of co-authors of Anna Żółkiewska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Żółkiewska. A scholar is included among the top collaborators of Anna Żółkiewska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Żółkiewska. Anna Żółkiewska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zubcevic, Lejla, et al.. (2022). Human mitochondrial AAA+ ATPase SKD3/CLPB assembles into nucleotide-stabilized dodecamers. Biochemical and Biophysical Research Communications. 602. 21–26. 14 indexed citations
4.
Žółkiewski, Michal, et al.. (2020). Human CLPB forms ATP-dependent complexes in the mitochondrial intermembrane space. The International Journal of Biochemistry & Cell Biology. 127. 105841–105841. 14 indexed citations
5.
Duhachek-Muggy, Sara, et al.. (2016). Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells. Breast Cancer Research and Treatment. 157(2). 241–252. 31 indexed citations
6.
Qi, Yue, Sara Duhachek-Muggy, Hui Li, & Anna Żółkiewska. (2014). Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12. PLoS ONE. 9(3). e92536–e92536. 12 indexed citations
7.
Li, Hui, et al.. (2012). An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer. Breast Cancer Research and Treatment. 135(3). 759–769. 30 indexed citations
8.
Fukada, So‐ichiro, Masahiko Yamaguchi, Hiroki Kokubo, et al.. (2011). Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers. Development. 138(21). 4609–4619. 123 indexed citations
9.
Li, Hui, et al.. (2011). Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29. Journal of Biological Chemistry. 286(24). 21500–21510. 33 indexed citations
10.
Li, Hui, et al.. (2010). The Role of SnoN in Transforming Growth Factor β1-induced Expression of Metalloprotease-Disintegrin ADAM12. Journal of Biological Chemistry. 285(29). 21969–21977. 29 indexed citations
11.
Sun, Danqiong, et al.. (2008). Breast cancer‐associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. International Journal of Cancer. 122(11). 2634–2640. 28 indexed citations
12.
Sun, Danqiong, et al.. (2006). Proteolytic Processing of Delta-like 1 by ADAM Proteases. Journal of Biological Chemistry. 282(1). 436–444. 103 indexed citations
13.
Yi, Haiqing, et al.. (2005). Cooperation of the Metalloprotease, Disintegrin, and Cysteine-rich Domains of ADAM12 during Inhibition of Myogenic Differentiation. Journal of Biological Chemistry. 280(25). 23475–23483. 15 indexed citations
14.
Zhao, Zhefeng, Joanna Gruszczynska‐Biegala, Haiqing Yi, et al.. (2004). Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin α7β1. Experimental Cell Research. 298(1). 28–37. 31 indexed citations
15.
Liu, Zhonghua, Anna Żółkiewska, & Michal Žółkiewski. (2003). Characterization of human torsinA and its dystonia-associated mutant form. Biochemical Journal. 374(1). 117–122. 53 indexed citations
16.
Kang, Qing, Yi Cao, & Anna Żółkiewska. (2001). Direct Interaction between the Cytoplasmic Tail of ADAM 12 and the Src Homology 3 Domain of p85α Activates Phosphatidylinositol 3-Kinase in C2C12 Cells. Journal of Biological Chemistry. 276(27). 24466–24472. 36 indexed citations
17.
Żółkiewska, Anna, Walter C. Thompson, & Joel Moss. (1998). Interaction of Integrin α7β1 in C2C12 Myotubes and in Solution with Laminin. Experimental Cell Research. 240(1). 86–94. 5 indexed citations
18.
Żółkiewska, Anna & Joel Moss. (1997). The α7 Integrin as a Target Protein for Cell Surface Mono-ADP-Ribosylation in Muscle Cells. Advances in experimental medicine and biology. 419. 297–303. 8 indexed citations
19.
Żółkiewska, Anna, Ian J. Okazaki, & Joel Moss. (1994). Vertebrate mono-ADP-ribosyltransferases. Molecular and Cellular Biochemistry. 138(1-2). 107–112. 22 indexed citations
20.
Żółkiewska, Anna, Barbara Zabłocka, Jerzy Duszyński, & Lech Wojtczak. (1989). Resting state respiration of mitochondria: Reappraisal of the role of passive ion fluxes. Archives of Biochemistry and Biophysics. 275(2). 580–590. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026